Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)
PaperCitations, authors & open-access status
Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 113 citations, 2014 year and bronze oa status.
113
Citations
2014
Year
bronze
OA Status